SEO URLwww.firestrike.ai/deals/avadel-pharmaceuticals-alkermes-acquisition-2026-3
acquisitionAnnounced · Feb 12, 2026biopharmaceuticalSource · CredibleArticle · Factual
Alkermes acquires Avadel Pharmaceuticals
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.1B
Target
Avadel Pharmaceuticals
NASDAQ: AVDL · Dublin, Leinster
Acquirer
Alkermes
Full Acquisition
Status
Pending
Alkermes agreed to acquire Avadel Pharmaceuticals. Reported deal value: $2.1B. Status: Pending. Sector: biopharmaceutical. Target headquarters context: Dublin, Leinster, Ireland.
This page summarizes publicly available information about the transaction as of 2026-02-12. Figures and status may change as filings and press coverage update.
Alkermes plc completes acquisition of Avadel Pharmaceuticals plc , accelerating entry into sleep medicine market Alkermes plc : Alkermes plc completes acquisition of Avadel Pharmaceuticals plc , accelerating entry into sleep medicine market Alkermes plc
Deal timeline
Announced
Feb 12, 2026 · marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical with a reported deal value of $2.1B. Figures and status may change as sources update.
Sources: marketscreener.com · Primary article · FireStrike proprietary index